444 related articles for article (PubMed ID: 22010182)
1. Thyroid dysfunction from antineoplastic agents.
Hamnvik OP; Larsen PR; Marqusee E
J Natl Cancer Inst; 2011 Nov; 103(21):1572-87. PubMed ID: 22010182
[TBL] [Abstract][Full Text] [Related]
2. Thyroid dysfunction as an unintended side effect of anticancer drugs.
Torino F; Barnabei A; Paragliola R; Baldelli R; Appetecchia M; Corsello SM
Thyroid; 2013 Nov; 23(11):1345-66. PubMed ID: 23750887
[TBL] [Abstract][Full Text] [Related]
3. [Endocrine complications of modern cancer therapy].
Čáp J
Vnitr Lek; 2016; 62(9 Suppl 3):45-49. PubMed ID: 27734691
[TBL] [Abstract][Full Text] [Related]
4. Thyrotoxicosis after denileukin diftitox therapy in patients with mycosis fungoides.
Ghori F; Polder KD; Pinter-Brown LC; Hoff AO; Gagel RF; Sherman SI; Duvic M
J Clin Endocrinol Metab; 2006 Jun; 91(6):2205-8. PubMed ID: 16595600
[TBL] [Abstract][Full Text] [Related]
5. Bexarotene and DAB(389)IL-2 (denileukin diftitox, ONTAK) in treatment of cutaneous T-cell lymphomas: algorithms.
Duvic M
Clin Lymphoma; 2000 Nov; 1 Suppl 1():S51-5. PubMed ID: 11707865
[TBL] [Abstract][Full Text] [Related]
6. Re: Thyroid dysfunction from antineoplastic agents.
Hercbergs AA; Garfield D; Ashur-Fabian O; Davis PJ
J Natl Cancer Inst; 2012 Mar; 104(5):422-3; author reply 423. PubMed ID: 22291212
[No Abstract] [Full Text] [Related]
7. [Thyroid dysfunctions in patients with viral hepatitis treated with interferon-alpha].
Földes I; Dávid K; Horváth G; Osztrogonácz H; Jankovics K; Tolvaj G
Orv Hetil; 2004 Jun; 145(23):1211-6. PubMed ID: 15264588
[TBL] [Abstract][Full Text] [Related]
8. Interaction of interferon alpha therapy with thyroid function tests in the management of hepatitis C: a case report.
Gill G; Bajwa H; Strouhal P; Buch HN
J Med Case Rep; 2016 Sep; 10(1):253. PubMed ID: 27632981
[TBL] [Abstract][Full Text] [Related]
9. Radioactive iodine thyroid uptake in patients with amiodarone-iodine-induced thyroid dysfunction.
Martino E; Bartalena L; Mariotti S; Aghini-Lombardi F; Ceccarelli C; Lippi F; Piga M; Loviselli A; Braverman L; Safran M
Acta Endocrinol (Copenh); 1988 Oct; 119(2):167-73. PubMed ID: 2845689
[TBL] [Abstract][Full Text] [Related]
10. [Rare differential diagnosis of hyperthyroidism].
Besemer B; Müssig K
Dtsch Med Wochenschr; 2016 Jun; 141(12):889. PubMed ID: 27305306
[TBL] [Abstract][Full Text] [Related]
11. Bexarotene-induced hypothyroidism: bexarotene stimulates the peripheral metabolism of thyroid hormones.
Smit JW; Stokkel MP; Pereira AM; Romijn JA; Visser TJ
J Clin Endocrinol Metab; 2007 Jul; 92(7):2496-9. PubMed ID: 17440015
[TBL] [Abstract][Full Text] [Related]
12. Etiology, diagnosis, and treatment recommendations for central hypothyroidism associated with bexarotene therapy for cutaneous T-cell lymphoma.
Sherman SI
Clin Lymphoma; 2003 Mar; 3(4):249-52. PubMed ID: 12672276
[TBL] [Abstract][Full Text] [Related]
13. Serum interleukin-6 in amiodarone-induced thyrotoxicosis.
Bartalena L; Grasso L; Brogioni S; Aghini-Lombardi F; Braverman LE; Martino E
J Clin Endocrinol Metab; 1994 Feb; 78(2):423-7. PubMed ID: 8106631
[TBL] [Abstract][Full Text] [Related]
14. Hypothyroidism: a growing complication of cancer treatment.
Kurtin SE
Oncology (Williston Park); 2009 Oct; 23(11 Suppl Nurse Ed):41-5. PubMed ID: 19856608
[TBL] [Abstract][Full Text] [Related]
15. Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha.
Roti E; Minelli R; Giuberti T; Marchelli S; Schianchi C; Gardini E; Salvi M; Fiaccadori F; Ugolotti G; Neri TM; Braverman LE
Am J Med; 1996 Nov; 101(5):482-7. PubMed ID: 8948271
[TBL] [Abstract][Full Text] [Related]
16. [Thyroid and treatment with amiodarone diagnosis, therapy and clinical management].
Mikosch P
Wien Med Wochenschr; 2008; 158(1-2):29-35. PubMed ID: 18286247
[TBL] [Abstract][Full Text] [Related]
17. A phase-1 trial of bexarotene and denileukin diftitox in patients with relapsed or refractory cutaneous T-cell lymphoma.
Foss F; Demierre MF; DiVenuti G
Blood; 2005 Jul; 106(2):454-7. PubMed ID: 15811959
[TBL] [Abstract][Full Text] [Related]
18. [Interferon-alpha-induced disorders of thyroid function. A retrospective analysis of the literature and personal experiences].
Weissel M; Templ E; Gisslinger H
Acta Med Austriaca; 1995; 22(1-2):1-5. PubMed ID: 7645363
[TBL] [Abstract][Full Text] [Related]
19. Interferon-alpha induced thyroid dysfunction: three clinical presentations and a review of the literature.
Koh LK; Greenspan FS; Yeo PP
Thyroid; 1997 Dec; 7(6):891-6. PubMed ID: 9459633
[TBL] [Abstract][Full Text] [Related]
20. [Amiodarone-induced thyroid gland dysfunctions].
Gassanov N; Dietlein M; Caglayan E; Erdmann E; Er F
Dtsch Med Wochenschr; 2010 Apr; 135(16):807-11. PubMed ID: 20391312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
